S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
NASDAQ:NTRA

Natera - NTRA Competitors

$56.65
+0.95 (+1.71%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$54.32
$56.72
50-Day Range
$39.72
$58.29
52-Week Range
$27.35
$59.75
Volume
917,175 shs
Average Volume
1.64 million shs
Market Capitalization
$6.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$79.27

NTRA vs. GH, EXAS, DGX, LH, ACHC, DOCS, NVST, LEGN, ASND, and STVN

Should you be buying Natera stock or one of its competitors? The main competitors of Natera include Guardant Health (GH), Exact Sciences (EXAS), Quest Diagnostics (DGX), Laboratory Co. of America (LH), Acadia Healthcare (ACHC), Doximity (DOCS), Envista (NVST), Legend Biotech (LEGN), Ascendis Pharma A/S (ASND), and Stevanato Group (STVN). These companies are all part of the "medical" sector.

Natera vs.

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

Natera has a net margin of -66.79% compared to Guardant Health's net margin of -145.61%. Natera's return on equity of -106.67% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health -145.61% -242.65% -35.89%
Natera -66.79% -106.67% -47.48%

In the previous week, Natera had 9 more articles in the media than Guardant Health. MarketBeat recorded 12 mentions for Natera and 3 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.22 beat Natera's score of 0.00 indicating that Guardant Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Natera
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$449.54 million5.52-$654.59 million-$6.40-3.78
Natera$820.22 million7.82-$547.80 million-$5.57-10.17

90.4% of Guardant Health shares are owned by institutional investors. Comparatively, 93.8% of Natera shares are owned by institutional investors. 5.9% of Guardant Health shares are owned by company insiders. Comparatively, 10.3% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Guardant Health currently has a consensus target price of $57.64, indicating a potential upside of 138.39%. Natera has a consensus target price of $79.27, indicating a potential upside of 39.93%. Given Guardant Health's higher probable upside, analysts clearly believe Guardant Health is more favorable than Natera.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
0 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.85
Natera
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Guardant Health has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Natera received 181 more outperform votes than Guardant Health when rated by MarketBeat users. Likewise, 68.81% of users gave Natera an outperform vote while only 68.61% of users gave Guardant Health an outperform vote.

CompanyUnderperformOutperform
Guardant HealthOutperform Votes
247
68.61%
Underperform Votes
113
31.39%
NateraOutperform Votes
428
68.81%
Underperform Votes
194
31.19%

Summary

Natera beats Guardant Health on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NTRA vs. The Competition

MetricNateraMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$6.42B$1.81B$4.34B$5.89B
Dividend YieldN/A2.67%2.39%4.42%
P/E Ratio-10.1716.44150.5615.55
Price / Sales7.8281.343,474.7060.82
Price / CashN/A6.5227.48103.34
Price / Book7.844.134.474.95
Net Income-$547.80M-$117.51M$115.09M$190.72M
7 Day Performance0.04%-2.03%-0.82%0.70%
1 Month Performance18.69%-7.71%-6.59%-6.02%
1 Year Performance42.70%-29.25%-16.05%-18.22%

Natera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GH
Guardant Health
2.7996 of 5 stars
$25.14
-5.3%
$57.64
+129.3%
-59.4%$2.58B$449.54M-3.931,793
EXAS
Exact Sciences
2.2754 of 5 stars
$64.17
-3.4%
$74.14
+15.5%
-1.2%$11.44B$2.08B-18.136,400
DGX
Quest Diagnostics
2.99 of 5 stars
$134.32
-1.2%
$150.91
+12.4%
-1.4%$14.95B$9.88B16.9649,000
LH
Laboratory Co. of America
3.2792 of 5 stars
$216.99
-2.0%
$283.50
+30.7%
-19.5%$19.20B$14.88B15.6680,000Positive News
ACHC
Acadia Healthcare
2.6468 of 5 stars
$69.80
-1.6%
$89.67
+28.5%
+8.3%$6.37B$2.61B23.2723,000
DOCS
Doximity
2.5337 of 5 stars
$32.56
-1.0%
$40.50
+24.4%
-35.1%$6.30B$343.55M59.20850News Coverage
NVST
Envista
2.1195 of 5 stars
$38.09
-2.6%
$46.00
+20.8%
-23.6%$6.22B$2.57B27.8012,700
LEGN
Legend Biotech
1.3723 of 5 stars
$43.66
-2.9%
$69.33
+58.8%
+18.6%$6.74B$89.79M-29.501,071Analyst Report
News Coverage
ASND
Ascendis Pharma A/S
1.713 of 5 stars
$105.55
-3.1%
$160.50
+52.1%
-10.1%$6.03B$53.93M-9.73639
STVN
Stevanato Group
2.4819 of 5 stars
€23.03
-1.6%
€29.00
+25.9%
+25.4%$6.81B$1.04B41.135,260
This page (NASDAQ:NTRA) was last updated on 3/25/2023 by MarketBeat.com Staff